MIDLOTHIAN, Va., Oct. 22 In the October supplement of USRespiratory Report, Dr. Donald Tashkin will follow-up his significant studycomparing the effectiveness of nebulizers and metered dose inhalers ...
MIDLOTHIAN, Va., Sept. 29, 2021 /PRNewswire/ -- Pulmotect reported positive topline results from their randomized, placebo-controlled Phase-2 trial of PUL-042 against COVID-19. Patients treated with ...
MIDLOTHIAN, Va., March 10 PARI's LC STAR nebulizer andPRONEB Ultra II compressor are the exclusive delivery devices for InspirePharmaceuticals' (Nasdaq: ISPH) second Phase 3 clinical trial for a ...
MIDLOTHIAN, Va., May 7, 2020 /PRNewswire/ -- This week, the first patients are enrolling in two phase 2 clinical trials for COVID-19 using Pulmotect's PUL-042, an inhaled immunomodulatory agent to ...
Respiratory devicemaker PARI picked up an approval from the FDA for its eRapid nebulizer system, which is the first electronic one to deliver Genentech's cystic fibrosis treatment Pulmozyme. A ...
STARNBERG, Germany, June 7, 2016 /PRNewswire/ -- PARI Pharma, a company focused on the development of advanced aerosol therapies using eFlow Technology, announces that its proprietary closed eFlow ...
DUBLIN--(BUSINESS WIRE)--The "Global Nebulizer Market 2017-2021" report has been added to Research and Markets' offering. The global nebulizer market is forecast to grow at a CAGR of 6.15% during the ...
Sellbyville, DE -- (SBWIRE) -- 06/18/2019-- Pneumatic Nebulizers Market size is set to exceed USD 875 million by 2024; according to a new research report by Global Market Insights. Rising elderly ...
Nebulizers, which help deliver medication in the form of a mist that a person inhales, may be useful for those with asthma and other respiratory conditions. Portable nebulizer machines make traveling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback